Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021
Thu, February 18, 2021
Wed, February 17, 2021
Tue, February 16, 2021
Mon, February 15, 2021
Fri, February 12, 2021
Thu, February 11, 2021

Cory Kasimov Downgraded (BLUE) to Hold and Decreased Target to $39 on, Feb 17th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-39-on-feb-17th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Cory Kasimov of JP Morgan, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Decreased Target from $76 to $39 on, Feb 17th, 2021.

Cory has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 2 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $50 on, Wednesday, November 11th, 2020
  • Matthew Luchini of "BMO Capital" Downgraded from Buy to Hold and Held Target at $56 on, Thursday, November 5th, 2020


These are the ratings of the 4 analyists that currently disagree with Cory


  • Yun Zhong of "Berenberg" Initiated at Strong Buy and Held Target at $64 on, Wednesday, November 11th, 2020
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $81 on, Thursday, November 5th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $99 on, Thursday, November 5th, 2020
  • Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $123 on, Tuesday, October 20th, 2020

Publication Contributing Sources